Chan Jean L, Blüher Susann, Yiannakouris Nikos, Suchard Marc A, Kratzsch Jurgen, Mantzoros Christos S
Division of Endocrinology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215, USA.
Diabetes. 2002 Jul;51(7):2105-12. doi: 10.2337/diabetes.51.7.2105.
Leptin is an adipocyte-secreted hormone important in energy homeostasis and diverse physiological processes. A circulating soluble form of the leptin receptor [soluble leptin receptor (sOB-R)] is the main leptin-binding protein and determinant of free leptin index (FLI), the presumed biologically active form of leptin. We performed observational and interventional studies to elucidate the regulation of sOB-R and FLI in humans. In a cross-sectional study (n = 118), leptin, gender, and adiposity were significant determinants of sOB-R. By multivariate analysis, estradiol (E2) and testosterone predict sOB-R, whereas insulin predicts leptin and FLI. In a frequent-sampling study (n = 6), sOB-R followed a significant circadian rhythm inverse to that of leptin, suggesting that leptin's biological activity may have an even more pronounced diurnal variation than originally thought. A 72-h fast in eight men decreased leptin levels by 80% and increased lymphocyte expression of leptin receptor mRNA and serum sOB-R levels by 100%. Physiological and pharmacological doses of recombinant-methionyl human leptin (rhLeptin) administered to fasted men prevented the fasting-induced increase of sOB-R levels, and pharmacological doses resulted in a decrease in sOB-R levels. These studies provide evidence that sOB-R is regulated by gender, adiposity, hormones, and rhLeptin administration. This may have important implications for the biological activity of leptin in disease states associated with abnormal leptin levels (e.g., obesity and anorexia nervosa).
瘦素是一种由脂肪细胞分泌的激素,在能量平衡和多种生理过程中发挥重要作用。循环中的可溶性瘦素受体[可溶性瘦素受体(sOB-R)]是主要的瘦素结合蛋白和游离瘦素指数(FLI)的决定因素,FLI被认为是瘦素的生物活性形式。我们进行了观察性和干预性研究,以阐明人类中sOB-R和FLI的调节机制。在一项横断面研究(n = 118)中,瘦素、性别和肥胖程度是sOB-R的重要决定因素。通过多变量分析,雌二醇(E2)和睾酮可预测sOB-R,而胰岛素可预测瘦素和FLI。在一项频繁采样研究(n = 6)中,sOB-R呈现出与瘦素相反的显著昼夜节律,这表明瘦素的生物活性可能具有比原先认为的更为明显的昼夜变化。八名男性进行72小时禁食后,瘦素水平降低了80%,淋巴细胞瘦素受体mRNA表达和血清sOB-R水平增加了100%。对禁食男性给予生理剂量和药理剂量的重组甲硫氨酰人瘦素(rhLeptin)可防止禁食诱导的sOB-R水平升高,药理剂量会导致sOB-R水平降低。这些研究提供了证据,表明sOB-R受性别、肥胖程度、激素和rhLeptin给药的调节。这可能对瘦素在与瘦素水平异常相关的疾病状态(如肥胖症和神经性厌食症)中的生物活性具有重要意义。